Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-03

Clinical Trial Update: Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population [NA]

View source ↗

Summary

A clinical trial comparing cytology and molecular screening for detecting cervical reactive cellular changes in the general population has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Timser SAPI de CV | Conditions: Atypical Squamous Cell of Undetermined Significance, ASC-US | NA | Status: WITHDRAWN